COVID-19 and income inequality in OECD countries: a methodological comment —a reply
(Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - August 13, 2023 Category: Health Management Source Type: research

Length of hospital stays and financial incentives: evidence from Dutch rehabilitation centers
AbstractNon-linear reimbursement contracts in healthcare have been increasingly used to quantify providers ’ responses to financial incentives. In the present research, we utilize a large one-off increase in the reimbursement of rehabilitation care to assess to what extent providers are willing to modify their treating behavior to maximize profits. In order to disincentivize the use of short inpatient stays for rehabilitation care, Dutch policy-makers have instated a two-part stepwise tariff-schedule. A lower tariff-schedule is applied for short hospital stays (≤ 14 days), while a higher tariff-schedule is utilized ...
Source: The European Journal of Health Economics - August 9, 2023 Category: Health Management Source Type: research

Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment
(Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - August 8, 2023 Category: Health Management Source Type: research

“COVID-19 and income inequality in OECD countries:” A methodological comment
AbstractWildman (2021), who identifies “a clear association between income inequality [measured by the Gini coefficient] and COVID-19 cases and deaths,” concludes that “a goal of government should be to reduce [income] inequalities and [thereby] improve [the COVID-19 outcomes /] underlying health of their populations.” In this Co mment, we argue that reducing the Gini coefficient of the income distribution of a population need not weaken the population’s social stress. It is this stress which is a source of adverse health outcomes of the population. Because a measure of this stress is acomponent of the Gini coeff...
Source: The European Journal of Health Economics - August 8, 2023 Category: Health Management Source Type: research

Losses of lifetime employment duration and productivity for patients with different subtypes and stages of lung cancer
ConclusionsEarly diagnosis of lung cancer would save the losses of employment duration and lifetime productivity. Future evaluation of the cost-effectiveness of lung cancer screening could consider incorporating these societal impacts. (Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - August 7, 2023 Category: Health Management Source Type: research

Using machine learning to estimate health spillover effects
AbstractWe develop a nonparametric model to study health spillover effects of policy interventions. We use double/debiased machine learning to estimate the model using data from 74 hospitals in Rio de Janeiro, Brazil, and examine cross-patient spillover effects during the COVID-19 pandemic. The pandemic forced hospitals to develop new protocols to offer intensive care to both COVID and non-COVID patients. Our results show that the need to care for COVID patients affects health outcomes of non-COVID patients. Controlling for a number of confounders, we find that mortality rates and length of stay of non-COVID ICU patients i...
Source: The European Journal of Health Economics - August 6, 2023 Category: Health Management Source Type: research

Immigrant assimilation in health care utilisation in Spain
AbstractAbundant evidence has tracked the labour market and health assimilation of immigrants, including static analyses of differences in how foreign-born and native-born residents consume health care services. However, we know much less about how migrants ’ patterns of healthcare usage evolve with time of residence, especially in countries providing universal or quasi-universal coverage. We investigate this process in Spain by combining all the available waves of the local health survey, which allows us to separately identify period, cohort, and as similation effects. We find robust evidence of migrant assimilation in ...
Source: The European Journal of Health Economics - July 31, 2023 Category: Health Management Source Type: research

Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland
ConclusionsT-DXd is cost-effective based on surrogate WTP thresholds of €72,000 and €139,000 per QALY. (Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - July 24, 2023 Category: Health Management Source Type: research

Disclosing the ‘Big C’: what does cancer survivorship signal to employers?
AbstractTo study hiring discrimination against cancer survivors, we conduct a vignette experiment in which American and British professionals recruited via Prolific evaluate fictitious job candidates. Candidates differed by periods of non-employment in their career, including non-employment due to suffering from cancer. We study the effect of cancer experiences on professionals ’ hirability ratings, as well as its effect on underlying candidate perceptions, related to various potential forms of stigma identified in the literature. We find that employment opportunities are lower for candidates with a history of cancer, co...
Source: The European Journal of Health Economics - July 22, 2023 Category: Health Management Source Type: research